GU Cancers 2023 | How can we improve outcomes for patients with kidney cancer who receive immunotherapy?

Mark Wayne Ball, MD, National Cancer Institute, National Institutes of Health, Bethesda, MD, talks on the importance of careful patient selection when using immunotherapy for patients with kidney cancer, and the need for further research into biomarkers in this area. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.